• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Bioniq Secures $15M to Expand AI-Driven Personalized Supplements Globally

by Jasmine Pennic 07/16/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Bioniq, the leading provider of personalized supplements based on blood biomarker data, raises $15M Series B funding led by prominent European venture capitalists HV Capital and Unbound, reaching a valuation of $75M. 

– The fresh capital will be used to propel Bioniq’s global market dominance and disrupt the traditional dietary supplements industry.

Personalized Supplements Driving Growth

Bioniq’s data-driven approach to personalized health solutions has seen impressive growth, particularly in the United States. The US market now comprises over half of Bioniq’s customer base, with some regions experiencing a staggering 500% surge in the past six months.

A key driver of Bioniq’s success is its ability to provide users with quantifiable results. Bioniq’s “before-and-after” snapshots of users’ nutrient needs and progress resonate with leading health and sports institutions like Lanserhof and UFC. This has positioned Bioniq as the supplement of choice for elite athletes, including Manchester United’s Diogo Dalot and former NBA All-Star Andrei Kirilenko, who rely on Bioniq to optimize their micronutrient levels and enhance performance and recovery.

Tailored Solutions for Individual Needs

Bioniq leverages over a decade of expertise to house the largest proprietary biochemical database in the industry. This data pool, alongside blood test information from customers worldwide, fuels Bioniq’s AI-powered algorithm. The algorithm analyzes an individual’s unique data points, including height, weight, age, lifestyle, and health goals, to pinpoint micronutrient imbalances and create a personalized supplement formula for optimal health.

Bioniq PRO: Hyper-Personalization with Blood Biomarker Data

The Bioniq PRO program caters to high performers and health enthusiasts seeking the ultimate level of personalization. This program integrates blood biomarker data into its algorithm. Users can either upload existing bloodwork or schedule a test through a Bioniq partner lab. The blood data is then meticulously analyzed to assess current nutrient status, identify deficiencies, and recommend a personalized daily supplement formula. Additionally, Bioniq PRO offers 1:1 consultations with registered dietitians to address individual needs and chart a personalized health journey.

Bioniq GO: Making Personalized Wellness More Accessible

Bioniq GO offers a more accessible entry point for users seeking personalized wellness solutions. This program utilizes Bioniq’s vast database and leverages a user questionnaire to guide the AI algorithm. Based on responses and anonymized blood biomarker data from previous users, the algorithm recommends a unique supplement blend tailored to the individual’s needs.

Quality and Innovation at the Core

Bioniq prioritizes quality and innovation. All Bioniq supplements are Swiss-made, pharmaceutical-grade, and utilize precise micro-dosing to address individual needs and deficiencies. Each formula is unique and features a customized blend of antioxidants, vitamins, minerals, phytonutrients, amino acids, and prebiotic fiber. Bioniq ditches traditional pills and capsules, opting for patented prebiotic guar granules that mimic the body’s natural digestion process, minimizing nutrient competition and maximizing bioavailability.

“We’ve entered a new era in nutritional supplementation over the last six years, where it’s become clear that one-size-fits-all solutions are simply inefficient,” said Vadim Fedotov, co-founder and CEO of Bioniq. “Everyone’s health journey is unique and fluid. Customers need advanced, adaptable products that provide evolving support for personal health goals. Our AI-driven approach and extensive biochemical database allow us to create customized supplements that provide quantifiable results and cater to individuals’ specific needs. Beyond meeting consumer demand, we’re setting a new standard in the industry by making the process and results transparent to the users.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |